Our AI-powered platform automatically pre-screens patients for eligibility and enables secure communication with trial sites. Sign up now to experience the future of clinical trial access.
myTomorrows simplifies the process of identifying clinical trials, pre-screening patients against eligibility criteria, and connecting with recruiting trial sites.
Our advanced search engine, paired with AI-powered precision pre-screening, provides an instant overview of relevant trial options and our GPDR-compliant and ISO27001-certified platform allows you to securely connect with site staff to discuss your patient’s medical profile.
myTomorrows is completely free-of-charge to patients and physicians, and our dedicated Medical Community team is here to support you every step of the way.
We’ve helped
With a community of
Across
A faster way to identify, pre-screen, and connect your patients with relevant clinical trial options—effortlessly and securely.
Access the most comprehensive clinical trial search engine, covering active trials in 200+ countries from trusted sources like ClinicalTrials.gov, EU Clinical Trials, and ISRCTN.
Instantly assess patient eligibility with AI-powered precision pre-screening that suggests relevant trial options based on your patient’s unique medical profile.
Discuss your patient’s medical profile with recruiting trial sites using a secure ISO 27001-certified, GDPR and HIPAA compliant chat and file sharing platform.
By signing up, you’ll be among the first to experience a smarter way to find and connect patients with clinical trials.
myTomorrows prioritizes patient privacy by ensuring that medical information is handled only with explicit patient consent and for a specific processing purpose. Our platform is GDPR- and HIPAA-compliant as well as ISO 27001-certified, providing a secure environment for processing sensitive data. Where local law permits, treating physicians can also securely upload and share patient records directly within the platform, but only after the patient’s explicit consent.
myTomorrows supports any disease areas where there is a high unmet medical need, such as oncology, rare diseases, and genetic diseases. Examples, among others, include neuromuscular diseases (incl. Duchenne muscular dystrophy, myotonic dystrophy etc.), type 1 diabetes, brain cancer, and lung cancer.
Thank you for contacting myTomorrows! Our team will be in touch soon.
Dr. Adam Fullagar, Clinical Oncologist, Royal Stoke Hospital